BCR-ABL1 expression in multiple myeloma cells: A case of mistaken identity?

被引：4
|
作者：
MacLeod, Roderick A. F. [1 ]
Nagel, Stefan [1 ]
Dirks, Wilhelm [1 ]
Drexler, Hans G. [1 ]
机构：
[1] Leibniz Inst DSMZ, Dept Human & Anim Cell Cultures, D-38124 Braunschweig, Germany
来源：
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 2013年 / 110卷 / 04期
关键词：
LEUKEMIA; LINES;
D O I：
10.1073/pnas.1219862110
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：E270 / E271
页数：2
相关论文
共 50 条
  • [31] Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression
    Bueno, Maria J.
    Perez de Castro, Ignacio
    de Cedron, Marta Gomez
    Santos, Javier
    Calin, George A.
    Cigudosa, Juan C.
    Croce, Carlo M.
    Fernandez-Piqueras, Jose
    Malumbres, Marcos
    CANCER CELL, 2008, 13 (06) : 496 - 506
  • [32] Hypoxia-inducible factor 1α inhibitor induces cell death via suppression of BCR-ABL1 and Met expression in BCR-ABL1 tyrosine kinase inhibitor sensitive and resistant chronic myeloid leukemia cells
    Tsubaki, Masanobu
    Takeda, Tomoya
    Matsuda, Takuya
    Kimura, Akihiro
    Tanaka, Remi
    Nagayoshi, Sakiko
    Hoshida, Tadafumi
    Tanabe, Kazufumi
    Nishida, Shozo
    BMB REPORTS, 2023, 56 (02) : 78 - 83
  • [33] Expression of BCR-ABL1 oncogene relative to ABL1 gene changes overtime in chronic myeloid leukemia
    Gupta, Manu
    Milani, Lili
    Hermansson, Monica
    Simonsson, Bengt
    Markevarn, Berit
    Syvdnen, Ann Christine
    Barbany, Gisela
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 366 (03) : 848 - 851
  • [34] BCR-ABL1 tyrosine kinase sustained MECOM expression in chronic myeloid leukaemia
    Roy, Swagata
    Jorgensen, Heather G.
    Roy, Poornima
    El Baky, Mohamed Abed
    Melo, Junia V.
    Strathdee, Gordon
    Holyoake, Tessa L.
    Bartholomew, Chris
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 (04) : 446 - 456
  • [35] EVALUATION OF REAGENTS FOR THE QUANTITATIVE MULTIPLEX MEASUREMENT OF BCR-ABL1 EXPRESSION ON THE INTERNATIONAL SCALE
    Brown, J.
    Hanfstein, B.
    Erben, P.
    Ackermann, K.
    Mueller, M.
    HAEMATOLOGICA, 2012, 97 : 535 - 535
  • [36] COMPARISON BETWEEN CEPHEID® GENEXPERT BCR-ABL ULTRA SYSTEM AND THE IPSOGEN® BCR-ABL1 MBCR IS-MMR KIT FOR THE STUDY OF BCR-ABL1 REARRANGEMENT IN CHRONIC MYELOID LEUKEMIA
    Naturil Rut, Meseguer
    Castillo Ivan, Martin
    Ribate Eva, Villamon
    Gavilan Pilar, Ortiz
    Paricio Fernando, Domingo
    Ferri Paula, Coll
    Navarro Julia, Ara
    Francisca, Garcia
    Noelia, Cabrera
    Lores Blanca, Ferrer
    HAEMATOLOGICA, 2021, 106 (10) : 177 - 177
  • [37] UK NEQAS LI BCR-ABL1 Quantitation Programme: impact of UK guidelines for BCR-ABL1 transcript quantitation in chronic myeloid leukaemia
    Clark, J. R.
    Jack, A. L.
    Barnett, D.
    Reilly, J. T.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 : 82 - 82
  • [38] BCR-ABL1 positive lymphoblastic lymphoma - should it be treated like a B-lymphoblastic leukemia with t(9;22);BCR-ABL1?
    Takahashi, Taro
    Ichikawa, Satoshi
    Ichinohasama, Ryo
    Harigae, Hideo
    LEUKEMIA & LYMPHOMA, 2020, 61 (05) : 1265 - 1267
  • [39] Neurotoxic events associated with BCR-ABL1 tyrosine kinase inhibitors: a case series
    Rafei, Hind
    Jabbour, Elias Joseph
    Kantarjian, Hagop
    Sinicrope, Kaylyn D.
    Kamiya-Matsuoka, Carlos
    Mehta, Rohtesh S.
    Daver, Naval G.
    Kadia, Tapan M.
    Naqvi, Kiran
    Cortes, Jorge
    Konopleva, Marina
    LEUKEMIA & LYMPHOMA, 2019, 60 (13) : 3292 - 3295
  • [40] ImatinibDevelopment of resistance in BCR-ABL1 KD mutated patients: 10 case reports
    Reactions Weekly, 2016, 1590 (1) : 114 - 114
12345